Meloni G - Search Results

1

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study.

Foa R, Meloni G, Tosti S, Novarino A, Fenu S, Gavosto F, Mandelli F. Foa R, et al. Among authors: meloni g. Br J Haematol. 1991 Apr;77(4):491-6. doi: 10.1111/j.1365-2141.1991.tb08615.x. Br J Haematol. 1991. PMID: 2025574

2

Interleukin 2 in the management of hematologic malignancies.

Foà R, Meloni G, Guarini A, Vignetti M, Mandelli F, Gavosto F. Foà R, et al. Among authors: meloni g. Pharmacol Res. 1992 Sep;26 Suppl 2:82-3. doi: 10.1016/1043-6618(92)90610-n. Pharmacol Res. 1992. PMID: 1409333 No abstract available.

3

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: meloni g. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

4

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Foa R, Meloni G, Guarini A, Vignetti M, Marchis D, Tosti S, Tos AG, Vischia F, Mandelli F, Gavosto F. Foa R, et al. Among authors: meloni g. Leukemia. 1992;6 Suppl 3:115S-116S. Leukemia. 1992. PMID: 1602806

5

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Meloni G, Foà R, Tosti S, Vignetti M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F. Meloni G, et al. Leukemia. 1992 Aug;6(8):780-5. Leukemia. 1992. PMID: 1640729

6

Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.

Foa R, Guarini A, Gillio Tos A, Cardona S, Fierro MT, Meloni G, Tosti S, Mandelli F, Gavosto F. Foa R, et al. Among authors: meloni g. Cancer Res. 1991 Feb 1;51(3):964-8. Cancer Res. 1991. PMID: 1988139

7

IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.

Meloni G, Foà R, Tosti S, Vignetti M, Gavosto F, Mandelli F. Meloni G, et al. Haematologica. 1990 Nov-Dec;75(6):502-5. Haematologica. 1990. PMID: 2098290

8

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

Foa R, Meloni G, Tosti S, Novarino A, Fenu S, Guarini A, Cardona S, Gillio Tos A, Gavosto F, Mandelli F. Foa R, et al. Among authors: meloni g. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:98-102. Bone Marrow Transplant. 1990. PMID: 2202476 Clinical Trial. No abstract available.

9

Interleukin-3 priming in acute myeloid leukaemia patients.

Tafuri A, de Felice L, Goodacre A, Fenu S, Petrucci MT, Valentini T, Alimena G, Petti MC, Meloni G, Mandelli F, et al. Tafuri A, et al. Among authors: meloni g. Br J Haematol. 1995 Sep;91(1):234-44. doi: 10.1111/j.1365-2141.1995.tb05276.x. Br J Haematol. 1995. PMID: 7577641

10

Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

Meloni G, Foa R, Vignetti M, Guarini A, Fenu S, Tosti S, Tos AG, Mandelli F. Meloni G, et al. Blood. 1994 Oct 1;84(7):2158-63. Blood. 1994. PMID: 7919330 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters